Business
Diabetes and Behavioral Health Global Experts Join DarioHealth Scientific Advisory Board Expanding Innovation Leadership in Digital Therapeutics for Chronic Care
Dr. Marilyn Ritholz, psychologist at Joslin Diabetes Center, a Harvard Medical School affiliate, and Dr. David Horwitz, former Global Chief Medical Officer of
About this update from Dariohealth Corp.
[{"type":"text","content":"Dr. Marilyn Ritholz, psychologist at Joslin Diabetes Center, a Harvard Medical School affiliate, and Dr. David Horwitz, former Global Chief Medical Officer of Johnson and Johnson Diabetes Institute, will help guide strategic and development roadmap\n\n\nNEW YORK, Jan. 13, 2021 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics (DTx) market, announced today that Dr. Marilyn Ritholz and Dr. David Horwitz will join Chairman Eric Milledge on its Scientific Advisory Board (SAB), advancing Dario's technical leadership and helping to guide the development of its bold technology roadmap. Dr. Ritholz and Dr. Horwitz are recognized for their expertise in diabetes, metabolism, and behavioral health.\n\n \n \n \n \n \n \n\n \nThe SAB mission is to advance Dario's DTx platform by integrating members' comprehensive experience and expertise into Dario's offering. The SAB will work with Dario's clinical and commercial teams to broaden and strengthen Dario's offering for the management of chronic conditions. We anticipate that the assistance of the SAB will help promote increased stakeholder awareness and deeper market penetration of the Dario platform, in addition to improving the health of individuals.\nWe believe that combining the Dario research and development (R&D) team and the SAB's expertise further strengthens Dario's next-generation, AI-powered, digital therapeutic solutions and advances its approach of supporting more than just an individual's disease. Dario provides adaptive, personalized experiences that drive behavior change through intuitive, clinically proven digital tools and coaching to help individuals improve health and sustain meaningful outcomes. \n\"Dario's platform was built, from the beginning, with a person-centric approach. Over time, its evolution has been driven by billions of consumer data points and constant refinement by our R&D team. We believe that these inputs have created a better system for managing chronic diseases,\" said Erez Raphael, Dario's Chief Executive Officer. \"With the addition of these SAB members, I believe that the Dario platform will continue its evolution with the integration of their years of clinical, provider, patient, and business experiences. I welcome their contributions and partnership as we build a digital care platform for the future.\" \nD...